OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands
Rick I. Meijer, Trynke Hoekstra, Niels C. Gritters van den Oever, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 2, pp. 1155-1160
Open Access | Times Cited: 13
Rick I. Meijer, Trynke Hoekstra, Niels C. Gritters van den Oever, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 2, pp. 1155-1160
Open Access | Times Cited: 13
Showing 13 citing articles:
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Nam Nhat Nguyen, Dung Si Ho, Hung Song Nguyen, et al.
Metabolism (2022) Vol. 131, pp. 155196-155196
Open Access | Times Cited: 68
Nam Nhat Nguyen, Dung Si Ho, Hung Song Nguyen, et al.
Metabolism (2022) Vol. 131, pp. 155196-155196
Open Access | Times Cited: 68
The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
Yidan Chen, Xingfei Lv, Sang Lin, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
Yidan Chen, Xingfei Lv, Sang Lin, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 34
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1395-1412
Open Access | Times Cited: 16
Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1395-1412
Open Access | Times Cited: 16
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID ‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation
Marina V. Shestakova, O. K. Vikulova, A. R. Elfimova, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Marina V. Shestakova, O. K. Vikulova, A. R. Elfimova, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
The Functions of SARS-CoV-2 Receptors in Diabetes-Related Severe COVID-19
Adam Drzymała
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9635-9635
Open Access | Times Cited: 3
Adam Drzymała
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9635-9635
Open Access | Times Cited: 3
Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Primary care diabetes (2021) Vol. 16, Iss. 1, pp. 162-167
Open Access | Times Cited: 21
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Primary care diabetes (2021) Vol. 16, Iss. 1, pp. 162-167
Open Access | Times Cited: 21
Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis
Kegang Zhan, Liuqi Weng, Qi Li, et al.
Annals of Pharmacotherapy (2022) Vol. 57, Iss. 7, pp. 776-786
Open Access | Times Cited: 9
Kegang Zhan, Liuqi Weng, Qi Li, et al.
Annals of Pharmacotherapy (2022) Vol. 57, Iss. 7, pp. 776-786
Open Access | Times Cited: 9
Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 4
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 4
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong
Carlos King Ho Wong, David Tak Wai Lui, Angel Y. C. Lui, et al.
Diabetes & Metabolism (2021) Vol. 48, Iss. 1, pp. 101307-101307
Open Access | Times Cited: 9
Carlos King Ho Wong, David Tak Wai Lui, Angel Y. C. Lui, et al.
Diabetes & Metabolism (2021) Vol. 48, Iss. 1, pp. 101307-101307
Open Access | Times Cited: 9
Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
Limin Zhao, Xiehui Chen, Mei Qiu
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 3
Limin Zhao, Xiehui Chen, Mei Qiu
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 3
Does DPP-4 inhibitor treatment affect the clinical outcomes of COVID-19 in type 2 diabetes mellitus patients?
Rumeysa Selvinaz Erol
Northern Clinics of Istanbul (2022)
Open Access | Times Cited: 2
Rumeysa Selvinaz Erol
Northern Clinics of Istanbul (2022)
Open Access | Times Cited: 2
Inhibitors of dipeptidyl-peptidase-4: obvious and probable (literature review)
Э А Ортенберг, Л. А. Суплотова
Meditsinskiy sovet = Medical Council (2022), Iss. 10, pp. 40-45
Open Access | Times Cited: 1
Э А Ортенберг, Л. А. Суплотова
Meditsinskiy sovet = Medical Council (2022), Iss. 10, pp. 40-45
Open Access | Times Cited: 1
